我国药品流通领域存在的问题及对策研究  

Problems and Reform Strategies of Medicines Distribution System in China

作　　者：赵建军[1] 孙静[1] 刘远立[1] 

机构地区：[1]中国医学科学院/北京协和医学院公共卫生学院,北京100730

出　　处：《中国药房》2017年第18期2459-2463,共5页China Pharmacy

基　　金：中央级公益性科研究院所基本项目;国家卫生计生委药政司委托研究课题(No.药政[2016]9号)

摘　　要：目的:为我国药品流通领域改革提出政策建议。方法:梳理我国药品流通领域的现状,分析存在的问题及影响因素,并给出改革建议。结果与结论:我国药品流通行业处于快速发展和变革时期,各流通企业存在规模小、集中度低、费用率高、营利能力低、经营模式单一、缺乏核心竞争力和面临新型业态发展挑战等问题。大批医药企业目前仍然延续传统的产供销经营模式,对供应链管理缺乏全面、清晰的认识和了解,自身定位尚在摸索中,而医药电商自身发展机遇与挑战并存。药品流通业需要进行纵向和横向一体化整合,加快社会化"第三方"物流和医药电商的健康发展,并健全和完善适应新型业态健康发展的药品流通监管体系。OBJECTIVE： To provide policy recommendations for optimizing medicines distribution system reform in China.METHODS： Literature review and field investigation were used to mapping the medicines distribution system. Problems and influential factors were analyzed and policy recommendations for optimizing the medicines distribution system reform were put forward. RESULTS ＆ CONCLUSIONS： Medicines distribution system has been undergoing a rapid development and transformation under the overall health system reform. Most medicines distributors are still with small scale, low concentration, high cost, low profitability, lack of core competence, development of new form facing challenges. A large number of drug distributors still follow the traditional business model, know little about modem drug supply chain management, and not understand their appropriate roles under the new social and economic development. Medical E-commerce face both opportunities and challenges in the process of developing. Drug distribution industry needs vertical and horizontal integration, speeds up the socialization of the third party logistics and the healthy development of the medical electricity supplier, improves and perfects the drug distribution supervision system which is suitable for the healthy development of new form.

关 键 词：药品流通 流通模式 供应链 对策 

分 类 号：R977[医药卫生—药品]